Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder

Cancer

Volumn 117, Issue 19, 2011, Pages 4540-4550

  Picarsic, Jennifer ^a   Jaffe, Ronald ^a   Mazariegos, George ^a   Webber, Steve A ^a   Ellis, Demetrius ^a   Green, Michael D ^a   Reyes Múgica, Miguel ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Burkitt lymphoma; EBV PTLD; Epstein Barr virus; pediatric oncology; pediatric transplant; post transplant lymphoproliferative disorder

Indexed keywords

CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; KI 67 ANTIGEN; METHOTREXATE; PREDNISONE; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE; VIRUS RNA;

ADOLESCENT; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MALE; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT BURKITT LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VIRUS LOAD;

ADOLESCENT; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 80052932942     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26001     Document Type: Article

References (35)

1. Shroff R, Rees L,. The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol. 2004; 19: 369-377. (Pubitemid 38477398)
2. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999; 68: 1851-1854. (Pubitemid 30027336)
3. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation. 1988; 45: 719-727.
4. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM,. Burkitt lymphoma. In:, Swerdlow SH, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008: 262-264.
5. Vakiani E, Basso K, Klein U, et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol. 2008; 26: 199-211.
6. Hamilton-Dutoit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 1993; 82: 619-624. (Pubitemid 23206130)
7. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J,. Histopathologic features of high-grade nonHodgkin's lymphomas in acquired immunodeficiency syndrome. The French study group of pathology for human immunodeficiency virus-associated tumors. Arch Pathol Lab Med. 1991; 115: 15-20.
8. Gulley ML, Tang W,. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn. 2008; 10: 279-292. (Pubitemid 352022708)
9. Windebank K, Walwyn T, Kirk R, et al. Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab. Pediatr Blood Cancer. 2009; 53: 392-396.
10. Pasquale MA, Weppler D, Smith J, et al. Burkitt lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pathol Oncol Res. 2002; 8: 105-108. (Pubitemid 34988059)
11. Tweddle DA, Gennery AR, Reid MM, et al. Posttransplantation B lymphoblastic leukemia with Burkitt-like features. Transplantation. 1999; 67: 1379-1380. (Pubitemid 29252418)
12. Gong JZ, Stenzel TT, Bennett ER, et al. Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of 5 cases. Am J Surg Pathol. 2003; 27: 818-827. (Pubitemid 36617520)
13. Hunt BJ, Thomas JA, Burke M, Walker H, Yacoub M, Crawford DH,. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient. Transplantation. 1996; 62: 869-872. (Pubitemid 26332858)
14. Riches J, Naresh K, Reid A, Macdonald D,. Burkitt lymphoma following renal transplantation. Br J Haematol. 2009; 146: 583.
15. Johnson LR, Nalesnik MA, Swerdlow SH,. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol. 2006; 30: 1604-1612. (Pubitemid 44808798)
16. Harris NL, Ferry JA, Swerdlow SH,. Posttransplant lymphoproliferative disorders: summary of society for hematopathology workshop. Semin Diagn Pathol. 1997; 14: 8-14. (Pubitemid 27078881)
17. Lohrisch CA, Nevill TJ, Barnett MJ, et al. Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma. Leuk Lymphoma. 2000; 39: 195-201. (Pubitemid 30657823)
18. Chang KL, Chen YY, Shibata D, Weiss LM,. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992; 1: 246-255.
19. Aguilera NS, Kapadia SB, Nalesnik MA, Swerdlow SH,. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol. 1995; 8: 503-508.
20. Dewald GW,. Chapter 32. In:, McClatchey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002: 11.
21. Wadowsky RM, Laus S, Green M, Webber SA, Rowe D,. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol. 2003; 41: 5245-5249. (Pubitemid 37429951)
22. Hwang YY, Wong KY, Leung RY, et al. Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression. Ann Hematol. 2009; 89: 97-99.
23. Schauer E, Webber S, Kingsley L, Green M, Rowe D,. Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein-Barr viral loads. Pediatr Transplant. 2009; 13: 311-318.
24. Leucci E, Cocco M, Onnis A, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol. 2008; 216: 440-450.
25. Sevilla DW, Gong JZ, Goodman BK, et al. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation. Am J Clin Pathol. 2007; 128: 981-991.
26. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood. 1991; 77: 1516-1526.
27. Metzelder M, Ure B,. Port-site metastasis after laparoscopic biopsy of a posttransplant Burkitt lymphoma in a child. Eur J Pediatr Surg. 2009; 19: 126-127.
28. Cacciarelli TV, Reyes J, Jaffe R, et al. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant. 2001; 5: 359-364. (Pubitemid 32834804)
29. Harris E, Paneesha S, Jackson N, Jones L, Mahendra P,. Burkitt's lymphoma: single-centre experience with modified BFM protocol. Clin Lab Haematol. 2002; 24: 111-114. (Pubitemid 35013551)
30. Smets F, Vajro P, Cornu G, Reding R, Otte JB, Sokal E,. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation. 2000; 69: 982-984. (Pubitemid 30174132)
31. Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006; 367: 233-239. (Pubitemid 43107668)
32. Dror Y, Greenberg M, Taylor G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation. 1999; 67: 990-998. (Pubitemid 29200849)
33. Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant. 2008; 8: 442-445.
34. Boccellato F, Anastasiadou E, Rosato P, et al. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in nonHodgkin's lymphoma cells. J Virol. 2007; 81: 2274-2282.
35. Capello D, Cerri M, Muti G, et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood. 2003; 102: 3775-3785. (Pubitemid 37409400)